Vastagbélrák: vizsgálatok itt: Spanyolország
147 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - 3. fázisTaking peopleSotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
- Where
- Badalona, Barcelona, Burgos, Córdoba, Elche, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona, Santander, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év to 64 év
- People
- 241 worldwide
- Run by
- Amgen Inc.
See details and how to join2022-502352-31-00 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Barcelona, Madrid
- Életkor
- 18 év to 100 év
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - No phaseNot yet taking people in SpanyolországPersonalised Behavioural Intervention in Cancer Screening Programmes
- Where
- Palma de Mallorca
- Életkor
- 50 év to 69 év
- People
- 162
- Run by
- Fundació d'investigació Sanitària de les Illes Balears
See details and how to joinNCT07722442 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - 1. fázisTaking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - 2. fázisTaking peopleRandomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus Bevacizumab Alone in Metastatic Colorectal Cancer Patients
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 35 worldwide
- Run by
- Delcath Systems Inc.
See details and how to join2024-520356-24-00 - 2. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Where
- Badalona, Barcelona, Córdoba, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 144 worldwide
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT06948448 - No phaseCsak meghívásosFrequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi
- Where
- Badalona
- Életkor
- 18 év and over
- People
- 150
- Run by
- Institut Català d'Oncologia
See details and how to joinNCT07697170 - 4. fázisTaking peopleEfficacy and Tolerability of a Simethicone-containing Evacuating Solution for Colorectal Cancer Screening Colonoscopy
- Where
- Barcelona
- Életkor
- 50 év to 69 év
- People
- 818
- Run by
- Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT07696793 - No phaseTaking peopleStage II/III Colorectal Cancer Recurrence
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06314958 - No phaseTaking peopleEarly Onset Colorectal Cancer Detection
- Where
- Barcelona, Madrid, Salamanca, San Cristóbal de La Laguna
- Életkor
- 18 év to 50 év
- People
- 400 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06342401 - No phaseTaking peopleEarly Detection of Advanced Adenomas and Colorectal Cancer
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06342440 - 1/2. fázisTaking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Barcelona, Córdoba, El Palmar, Madrid, Seville, Tarragona, Valencia
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - 1/2. fázisTaking peopleA Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 482 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07079631 · EU 2025-521768-36-00 - No phaseTaking peopleImpact of SMS Messaging on Participation in Colorectal Cancer Screening
- Where
- Sabadell
- Életkor
- 50 év to 69 év
- People
- 10 084
- Run by
- Corporacion Parc Tauli
See details and how to joinNCT07628998 - 2. fázisTaking peopleBevacizumab plus encorafenib-cetuximab in BRAF-V600E mutated metastatic colorectal cancer, a phase II study with a safety lead-in cohort, the BRAVE trial
- Where
- A Coruña, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo, Santander, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 94
- Run by
- Vall D Hebron Institute Of Oncology
See details and how to join2023-509204-15-00 - No phaseTaking peopleMesorectal Microbiome and Metabolome as a Prognostic Factor in Patients With Rectal Cancer
- Where
- Girona
- Életkor
- 18 év to 18 év
- People
- 100
- Run by
- University Hospital of Girona Dr. Josep Trueta
See details and how to joinNCT04804956 - 3. fázisTaking peopleEfficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer
- Where
- Córdoba
- Életkor
- 18 év to 75 év
- People
- 1083
- Run by
- Maimónides Biomedical Research Institute of Córdoba
See details and how to joinNCT06783491 · EU 2025-520471-29-00 - No phaseTaking peopleEfficacy and Safety of Transcutaneous Posterior Tibial Nerve Stimulation on Fecal Continence in Patients Undergoing Surgery for Rectal Neoplasia
- Where
- Manresa
- Életkor
- 18 év and over
- People
- 84
- Run by
- Althaia Xarxa Assistencial Universitària de Manresa
See details and how to joinNCT07632196 - No phaseTaking peopleA Mobile Application to Improve the Quality of Colonoscopy in Colorectal Cancer Screening Program (PrepColon APP)
- Where
- Valladolid
- Életkor
- 50 év to 74 év
- People
- 470
- Run by
- Hospital del Rio Hortega
See details and how to joinNCT06314022 - 1/2. fázisNot yet taking people in SpanyolországA Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Badalona, Hortaleza
- Életkor
- 18 év and over
- People
- 252 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07223047 - 1/2. fázisFut, nem toborozA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Barcelona, Madrid
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 1/2. fázisTaking peopleBeamion BCGC-1: A study to find a suitable dose of zongertinib used alone and in combination with other treatments to test whether it helps people with different types of HER2+ cancer that has spread
- Where
- A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 181 worldwide
- Run by
- Boehringer Ingelheim International GmbH
See details and how to join2023-509566-38-00